Sigal Kaplan

627 total citations
48 papers, 389 citations indexed

About

Sigal Kaplan is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sigal Kaplan has authored 48 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pediatrics, Perinatology and Child Health, 15 papers in Public Health, Environmental and Occupational Health and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sigal Kaplan's work include Pregnancy and Medication Impact (9 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Sigal Kaplan is often cited by papers focused on Pregnancy and Medication Impact (9 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Sigal Kaplan collaborates with scholars based in Israel, United States and France. Sigal Kaplan's co-authors include Thomas J. Moore, Sheila R. Weiss, Carol J. Blaisdell, Tarek A. Hammad, Massoud Toussi, B. Ehlken, Andrew D. Mosholder, G. D. Rochester, Sarah J. Beaton and Robert L. Davis and has published in prestigious journals such as Annals of Internal Medicine, PEDIATRICS and The American Journal of Cardiology.

In The Last Decade

Sigal Kaplan

44 papers receiving 370 citations

Peers

Countries citing papers authored by Sigal Kaplan

Since Specialization

Citations

This map shows the geographic impact of Sigal Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sigal Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sigal Kaplan more than expected).

Fields of papers citing papers by Sigal Kaplan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sigal Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sigal Kaplan. The network helps show where Sigal Kaplan may publish in the future.

Co-authorship network of co-authors of Sigal Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Sigal Kaplan. A scholar is included among the top collaborators of Sigal Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sigal Kaplan. Sigal Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Paternal Valproate Use and Neurodevelopmental Disorder and Congenital Malformation Risk in Offspring 2025 ·JAMA Network Open ·(unknown), (unknown), Ana Cristina Santos, Sigal Kaplan, Romina di Giuseppe, (unknown), (unknown), Marte‐Helene Bjørk, Marie‐Laure Kürzinger, Maria Roberta Cilio, Florent Richy	1
2	Experiences and perceptions of patients, caregivers, and healthcare professionals with long-acting injectable antipsychotics for the treatment of schizophrenia: qualitative results from the multinational ADVANCE study 2025 ·Frontiers in Psychiatry ·(unknown), Rolf Hansen, (unknown), (unknown), Martin Sergerie, Anna S. Levin, Sigal Kaplan, (unknown), (unknown), Stephan Heres, (unknown)	1
3	Attitudes Driving Regional Differences in Long-Acting Injectable Antipsychotic Utilization for Schizophrenia among Healthcare Professionals, Patients, and Caregivers (ADVANCE): Results from a Multinational Survey Study 2025 ·Schizophrenia Bulletin Open ·(unknown), Rolf Hansen, (unknown), (unknown), Anna S. Levin, Martin Sergerie, Sigal Kaplan, (unknown), Stephan Heres, (unknown)	0
4	Prevalence of multiple system atrophy: A literature review 2024 ·Revue Neurologique ·Sigal Kaplan	3
5	Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review 2024 ·Pharmacoepidemiology and Drug Safety ·Rosa Gini, Romin Pajouheshnia, Helga Gardarsdóttir, Dimitri Bennett, Lin Li, (unknown), Angelika Wientzek, Marloes T. Bazelier, Mehmet Burcu, Caitlin Dodd, Carlos E. Durán, Sigal Kaplan, Stephan Lanes, (unknown), Giuseppe Roberto, (unknown), Xiaofeng Zhou, Robert W. Platt, Soko Setoguchi, Gillian C. Hall	3
6	Effectiveness of the Additional Risk Minimisation Measures for Valproate Among Healthcare Professionals and Patients: A Cross‐Sectional Survey in Six European Countries 2024 ·Pharmacoepidemiology and Drug Safety ·(unknown), (unknown), (unknown), Sigal Kaplan, (unknown), (unknown), Marie‐Laure Kürzinger, Massoud Toussi	0
7	Estimating the prevalence and incidence of multiple system atrophy in the USA: Insights from a national claims database 2023 ·Parkinsonism & Related Disorders ·Sigal Kaplan, (unknown), Jing Wang	2
8	Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding 2022 ·Drug Safety ·Sigal Kaplan, (unknown), Tal Stern	9
9	Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States 2021 ·Contraception ·Sigal Kaplan, Monica L. Bertoia, Florence T. Wang, Li Zhou, Amir Lass, Alison Evans, (unknown), Debabrata Roy, John D. Seeger	2
10	Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study 2021 ·Frontiers in Endocrinology ·Sigal Kaplan, Rachel Levy-Toledano, (unknown), Debabrata Roy, Colin M. Howles, Amir Lass	5
11	Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry 2020 ·Journal of Cystic Fibrosis ·Sigal Kaplan, Andrew Lee, N Caine, Susan C. Charman, Diana Bilton	6
12	Pregnancy and Fetal Outcomes Following Exposure to Modafinil and Armodafinil During Pregnancy 2020 ·JAMA Internal Medicine ·Sigal Kaplan, Debra L. Braverman, (unknown), (unknown)	8
13	Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web Surveillance 2019 ·Drug Safety ·Sigal Kaplan, Aurore Bergamasco, Martin Sergerie, (unknown), Yola Moride	1
14	Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe 2019 ·Clinical Drug Investigation ·Daniel Fife, John Waller, Sigal Kaplan, Peter Hu, (unknown), Susan A. Oliveria, Ute Richarz	4
15	Challenges of post‐authorization safety studies: Lessons learned and results of a French study of fentanyl buccal tablet 2017 ·Pharmacoepidemiology and Drug Safety ·(unknown), (unknown), Sigal Kaplan, (unknown)	2
16	The Prevalence and Trends of Antiviral Medication Use During Pregnancy in the US: A Population-Based Study of 664,297 Deliveries in 2001–2007 2013 ·Maternal and Child Health Journal ·Lyndsay A. Avalos, Hong Chen, Chunmei Yang, Susan E. Andrade, William O. Cooper, (unknown), Robert L. Davis, Sascha Dublin, Tarek A. Hammad, Sigal Kaplan, Pamala A. Pawloski, Marsha A. Raebel, Pamela E. Scott, David H. Smith, Sengwee Toh, De‐Kun Li	5
17	Prevalence, Trends, and Patterns of Use of Antidiabetic Medications Among Pregnant Women, 2001-2007 2013 ·Obstetrics and Gynecology ·Jean M. Lawrence, Susan E. Andrade, Lyndsay A. Avalos, Sarah J. Beaton, Vicki Y. Chiu, Robert L. Davis, Sascha Dublin, Pamala A. Pawloski, Marsha A. Raebel, David H. Smith, Sengwee Toh, (unknown), Sigal Kaplan, (unknown), Christian Hampp, Tarek A. Hammad, Pamela E. Scott, T. Craig Cheetham	27
18	Antidepressant medication dispensing among montelukast initiators 2013 ·Journal of Asthma ·Esther H. Zhou, Sigal Kaplan, Andrew D. Mosholder, David Moeny, (unknown), (unknown), Solomon Iyasu, Tarek A. Hammad	9
19	In-hospital management of patients with atrial flutter 2010 ·American Heart Journal ·Nancy M. Allen LaPointe, Jie‐Lena Sun, Sigal Kaplan	2
20	Rhythm Versus Rate Control in the Contemporary Management of Atrial Fibrillation In-Hospital††The views expressed in this report are those of the investigators and do not necessarily represent the views of the FDA. 2008 ·The American Journal of Cardiology ·Nancy M. Allen LaPointe, Jie‐Lena Sun, Sigal Kaplan, (unknown), Sana M. Al‐Khatib	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact